Don't get too ex­cit­ed about Eli Lil­ly's up­com­ing Alzheimer's read­out just yet, R&D chief cau­tions

Eli Lil­ly will have re­sults soon from yet an­oth­er test it’s con­duct­ing on the amy­loid be­ta hy­poth­e­sis in Alzheimer’s. But don’t get your hopes up just yet.

In an un­usu­al move, R&D chief Dan Skovron­sky played down ex­pec­ta­tions for the DI­AN-TU tri­al, which en­rolled 490 pa­tients with a ge­net­ic mu­ta­tion that puts them at high­er risk for ear­ly on­set dis­ease. The place­bo-con­trolled study is eval­u­at­ing their solanezum­ab and Roche’s gan­tenerum­ab, both of which had failed de­ci­sive­ly in treat­ing ear­ly-stage Alzheimer’s.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER